Disposition of 976 shares by Zhen Marianne of Innoviva at 16.13 subject to Rule 16b-3

INVA Stock  USD 18.90  0.01  0.05%   
About 56% of Innoviva's investor base is looking to short. The analysis of overall sentiment of trading Innoviva stock suggests that many investors are alarmed at this time. The current market sentiment, together with Innoviva's historical and current headlines, can help investors time the market. In addition, many technical investors use Innoviva stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Innoviva Officer: Chief Accounting Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at macroaxis.com
Disposition of 976 common stock at 16.13 of Innoviva by Zhen Marianne on 20th of May 2024. This event was filed by Innoviva with SEC on 2024-05-20. Statement of changes in beneficial ownership - SEC Form 4

Innoviva Fundamental Analysis

We analyze Innoviva's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Innoviva using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Innoviva based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Probability Of Bankruptcy

Probability Of Bankruptcy Comparative Analysis

Innoviva is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Innoviva Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Innoviva stock to make a market-neutral strategy. Peer analysis of Innoviva could also be used in its relative valuation, which is a method of valuing Innoviva by comparing valuation metrics with similar companies.

Peers

Innoviva Related Equities

PDSBPDS Biotechnology   9.21   
0%
85.0%
ELEVElevation Oncology   8.06   
0%
74.0%
ABOSAcumen Pharmaceuticals   3.85   
0%
35.0%
APLSApellis Pharmaceuticals   3.12   
0%
28.0%
INZYInozyme Pharma   2.82   
0%
26.0%
HRMYHarmony Biosciences   1.85   
0%
17.0%
ARGXArgenx NV   1.67   
0%
15.0%
AMLXAmylyx Pharmaceuticals   1.45   
0%
13.0%
DNLIDenali Therapeutics   0.73   
0%
6.0%
FOLDAmicus Therapeutics   0.52   
0%
4.0%
HOOKHookipa Pharma   0.50   
0%
4.0%
PLXProtalix Biotherapeutics   0.42   
0%
3.0%
INCYIncyte   0.07   
0%
1.0%
DAWNDay One   1.51   
13.0%
0%
TERNTerns Pharmaceuticals   6.28   
58.0%
0%
XFORX4 Pharmaceuticals   10.81   
100.0%
0%

Complementary Tools for Innoviva Stock analysis

When running Innoviva's price analysis, check to measure Innoviva's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innoviva is operating at the current time. Most of Innoviva's value examination focuses on studying past and present price action to predict the probability of Innoviva's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innoviva's price. Additionally, you may evaluate how the addition of Innoviva to your portfolios can decrease your overall portfolio volatility.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets